The Multicentric Castleman's Disease (Mcd) -Symptom Scale (Mcd-Ss): Development and Validation of A Patient-Reported Outcome (Pro) Measure for An Ultra-Orphan Disease

Value Health. 2014 Nov;17(7):A535. doi: 10.1016/j.jval.2014.08.1709. Epub 2014 Oct 26.

Authors

C Casper¹, Agthoven M Van², M Rothman³, S Fleming⁴, K F Ho⁴, M Qi⁴, J Vermeulen⁵, J Cavet⁶

Affiliations

¹ Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
² Janssen-Cilag BV, Tilburg, The The Netherlands.
³ Janssen Global Services, LLC, Spring House, PA, USA.
⁴ Janssen R&D, US, Spring House, PA, USA.
⁵ Janssen, Leiden, The Netherlands.
⁶ Christie Hospital, Manchester, UK.

PMID: 27201708
DOI: 10.1016/j.jval.2014.08.1709

No abstract available